Angle Share Price (AGL)

51.00 -1.00 (-1.92%) delayed: 12:22AM BST
Bid price 50.00 Open price 51.00
Ask price 52.00 Prev close 51.00
High price 52.00 Spread 3.85%
Low price 50.05 Volume 99,265

Register now for FREE live Angle share prices, Angle stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Angle Level 2 Data, indepth research tools and investor commentary for Angle (AGL) and other London Stock Exchange equities.

Angle Share Price Chart

Advanced Charts >>

Register now for FREE Angle share price charts

Angle Share Price Information

Name Angle Epic AGL
Sector Pharmaceuticals & Biotechnology ISIN GB0034330679
Activites ANGLE plc is a world-leading liquid biopsy company commercialising a disruptive platform technology that can capture cells circulating in blood, such as cancer cells, even when they are as rare in number as one cell in one billion blood cells, and harvest the cells for analysis. ANGLE's cell separation technology is called the ParsortixTM system and it enables a liquid biopsy (simple blood test) to be used to provide the cells of interest. Parsortix is the subject of granted patents in Europe, the United States, Canada, India, China, Japan and Australia and three extensive families of patents are being progressed worldwide. The system is based on a microfluidic device that captures live cells based on a combination of their size and compressibility. The ParsortixTM system has a CE Mark for Europe and FDA authorisation is in process for the United States. ANGLE has established formal collaborations with world-class cancer centres. Index n/a

Angle Key Numbers

Latest Share Price (p) 51.00 Net Gearing (%) -31.36
Market Capitalisation (£m) 59.71 Gross Gearing (%) 19.34
Shares in issue (m) 117.09 Debt Ratio 0.00
P/E Ratio -5.86 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.24
Dividend Yield (%) 0.00 Price to book value 6.78
Dividend cover (x) 0.00 ROCE (%) -84.11
Earning per share (p) -8.71 EPS Growth (%) -0.81
52 week high / low 80.00 / 32.25 DPS Growth (%) n/a

Angle Director Deals

Dec.Date Type Director Pos No. of Shares
24/09/2009 BUY Andrew Newland CEO 200,000

More Angle Director Deals >>

Angle Company News

07:00 14/05/2018

Leading cancer surgeon appointed

RNS Number : 8891N Angle PLC 14 May 2018   For immediate release  14 May 2018   ANGLE plc ("the Company")   LEADING NHS PROSTATE CANCER SURGEON APPOINTED AS SCIENTIFIC ADVISOR     ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid...

07:00 03/05/2018

Angle & QIAGEN Poster

RNS Number : 9525M Angle PLC 03 May 2018   For immediate release  3 May 2018   ANGLE plc ("the Company")   ANGLE AND QIAGEN PRESENT POSTER AT LEADING CANCER CONFERENCE DEMONSTRATING UTILITY OF ANGLE'S PARSORTIX SYSTEM IN CONJUNCTION WITH QIAGEN'S...

More Angle Company News >>

Register now for FREE Angle company news

Angle Share Price Discussions

3 months ago

ANGLE - Share price 86p broker target 165p - SIGNIFICANTLY UNDERVALUED (AGL)

Two new broker notes out last week on this one - Collins Stewart gives a target valuation for the combined entity of £26 million or 156p per share Edison Investments embedded valuation is £31m - Indicating a 100% gain in share price from current levels. They suggest that using the current...

more than 1 year ago

Seeking more information on Angle PLC (AGL)

There seems to be increasingly positive RNS on Angle PLC. It seems they have a world-leading cancer diagnostic kit that is now being tested by the key cancer research labs in the world. The potential research market is £250mn pa, and the commercial market is £7.9bn according to their...

more than 1 year ago

angle (AGL)

http://www.angletechnology.com/ research note, acrobat reader needed latest results 24/1/06

Register now for FREE Angle share price discussions